Clinical Trial Detail

NCT ID NCT02878785
Title Decitabine and Talazoparib in Untreated AML and R/R AML (1565GCC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Maryland
Indications

acute myeloid leukemia

Therapies

Decitabine + Talazoparib

Age Groups: senior adult

No variant requirements are available.